"Usage, acceptability, and preliminary effectiveness of an mHealth-based integrated modality for smoking cessation interventions in Western China"

作者全名："Chu, Shuilian; Tong, Zhaohui; Zhang, Yuntao; Ye, Xianwei; Liu, Zhiyan; Chen, Hong; Bai, Jing; Li, Fengsen; Li, Xiaoping; Wang, Huaizhen; Wang, Rui; Wang, Xuefeng; Li, Jiachen; Liang, Siqiao; Nong, Ying; Wang, Xin; Wang, Ahong; Zhang, Di; Jing, Hang; Feng, Lin; Liang, Lirong"

作者地址："[Chu, Shuilian; Li, Jiachen; Zhang, Di; Jing, Hang; Feng, Lin; Liang, Lirong] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Res Tobacco Dependence Therapies, Beijing, Peoples R China; [Tong, Zhaohui; Wang, Rui] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Zhang, Yuntao] Peoples Hosp Lhasa Tibet, Dept Resp Med, Lhasa, Tibet Autonomou, Peoples R China; [Ye, Xianwei] Guizhou Prov Peoples Hosp, Dept Pulm & Crit Care Med, Guiyang, Peoples R China; [Liu, Zhiyan] Xian Third Hosp, Dept Resp & Crit Care Med, Xian, Peoples R China; [Chen, Hong] Chongqing Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Chongqing, Peoples R China; [Bai, Jing; Liang, Siqiao; Nong, Ying] Guangxi Med Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Nanning, Peoples R China; [Li, Fengsen; Wang, Xin] Xinjiang Med Univ, Affiliated Hosp Tradit Chinese Med, Dept Resp & Crit Care Med, Urumqi, Peoples R China; [Li, Xiaoping] First Peoples Hosp Zunyi, Dept Resp & Crit Care Med, Zunyi, Peoples R China; [Wang, Huaizhen] Kashgar Prefecture Second People s Hosp, Hosp Management Off, Kashgar, Peoples R China; [Wang, Xuefeng] Xining Second Peoples Hosp, Dept Resp & Crit Care Med, Xining, Peoples R China; [Wang, Ahong] Kashgar Prefecture Second Peoples Hosp, Dept Resp & Crit Care Med, Kashgar, Peoples R China"

通信作者："Liang, LR (通讯作者)，Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Res Tobacco Dependence Therapies, 8 Gong Ti Nan Lu, Beijing 100020, Peoples R China."

来源：TOBACCO INDUCED DISEASES

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001168031000001

JCR分区：Q2

影响因子：2.2

年份：2023

卷号：21

期号：　

开始页：　

结束页：　

文献类型：Article

关键词：　

摘要："INTRODUCTION Many smokers have not accessed professional smoking cessation assistance due to limited smoking cessation services. We developed a novel mHealth-based integrated modality for smoking cessation (WeChat + Quitline modality, WQ modality) and applied it to a large public welfare project (China Western-QUIT Program) in western China. This study evaluated the usage, acceptability, and preliminary effectiveness of the WQ modality in the population of western China. METHODS A prospective cohort study was conducted between April and August 2021. Smokers or their relatives were recruited through online advertisements and medical staff referrals. After using the services of the WQ modality for one month, the self-reported awareness, use, and satisfaction with each service among the participants were collected by a telephone interview. We also evaluated the self-reported 7-day point prevalence of abstinence (PPA) and quit attempt rate among baseline current smokers. The usage data of each service were downloaded from quitline and WeChat platforms. RESULTS Of the 17326 people from western China using the WQ modality, the largest number of users was WeChat official account (11173), followed by WeChat mini program (3734), WeChat group (669), and quitline (541 inbound calls, 605 outbound calls). At one month follow-up, over 70% of participants who completed the baseline survey (n=2221) were aware of WeChat-based services, and over 50% used them. However, the awareness rate (11.1%) and utilization rate (0.5%) of quitline were relatively low. The median satisfaction scores across all services were 9 out of 10 points (IQR: 8 & ndash;9). Among the baseline current smokers (n=1257), self-reported 7-day PPA was 41.8% (526/1257), and another 225 smokers (17.9%) reported making a quit attempt. CONCLUSIONS The WQ modality could be well used and accepted, and it has great potential to motivate and aid short-term smoking cessation in smokers from western China."

基金机构：World Health Organization (WHO Registration) [2021/1106617-0]; Beijing Key Specialists in Major Epidemic Prevention and Control

基金资助正文：This study was funded by World Health Organization (WHO Registration 2021/1106617-0) and Beijing Key Specialists in Major Epidemic Prevention and Control.